IL3RA and acute myeloid leukemia: Collectively, these features are poised to make CD123 aptamer ZW25 uniquely attractive for AML-targeted drug delivery system, and it is obvious that CD123 aptamer-mediated TDT has great potential application for the development of novel AML-targeted drug delivery system.